The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 40 | — | 20.1x | Near average | |
Growth | 89 | 666.0% | 5.6% | Above average | |
Quality | 13 | -35.8% | 7.6% | Below average | |
Safety | 77 | 0.1x | 0.4x | Above average | |
Capital Return | 38 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
CG Oncology, Inc. Common stock is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy CG Oncology, Inc. Common stock shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
CG Oncology stock shows remarkable stability in analyst estimates over the past 30 days, with the average price target steady at 82.57 dollars, representing a premium of approximately 28% over the current price. The data reflects a strong consensus from 6 analysts with limited Dispersion, as the price range fluctuates between 70 and 93 dollars, indicating high confidence in the stock's intrinsic value despite the absence of recent adjustments.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.